Oncolytics Biotech (ONCY) Tops Q3 EPS by 1c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.05), $0.01 better than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
• Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
• BlockchainK2 plans private placement to raise up to $130,000